Huntsville / Rockville / Boston / Beverly / Frederick / Namur / Livermore / /
Company
BP / Nikon / GenBank / Guttmacher A.E. / Ge / High-Tech Fund / 6Open Biosystems Inc. / Gateway / Nicot A.S. / Lawrence Livermore National Laboratory / Open Biosystems Inc. / LR / 7Agencourt Biosciences Corporation / Suzuki / Amersham / /
Country
Belgium / France / United States / / /
Facility
ORFeome Human ORFeome cDNA library / Farber Cancer Institute / Dana-Farber Cancer Institute / RNAi library / Applications International Corporation/National Cancer Institute / University of California / terminal GFP / / /
IndustryTerm
diverse expression systems / downstream omics applications / biological systems / expression systems / protein expression systems / molecular networks / reverse proteomics applications / by-products / gene products / protein chips / ligase technology / protein activities using proteome chips / proteome chips / Web site http /
MarketIndex
set 10 / /
MedicalCondition
ORF / target ORF / cognate ORF / human ORF / every ORF / each ORF / long ORF / individual ORF / unidirectional ORF / full-length ORF / expected ORF / relevant polymorphic ORF / /
MedicalTreatment
bypass / /
Organization
Harvard Medical School / Centre National / University of California / National Institute of Health / 4Science Applications International Corporation/National Cancer Institute / Vidal Lab / Dana-Farber Cancer Institute / Department of Genetics / Department of Cancer Biology / Center for Cancer Systems Biology / Ellison Foundation / /
Person
Andrews / Jane Song / Nat / Stan Korsmeyer / Carlene Fraughton / Ian Dunham / David Livingston / Boone / Thomas / David Bentley / Priya McCue / / /
Resource Human ORFeome Version 1.1: A Platform for Reverse Proteomics Jean-Franc¸ois Rual,1,2,9 Tomoko Hirozane-Kishikawa,1,9 Tong Hao,1,9 Nicolas Bertin,1,3,9 Siming Li,1,9 Amélie Dricot,1 Ning Li,1 Jennifer Rosenber